Paraaortal Lymphadenectomy in the Treatment of Ovarian Cancer
Freitag, Živný, Kužel, Adamec, Jančárková
Gynekologcko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. J. Živný, DrSc., Klinika transplantační chirurgie IKEM, Praha, přednosta doc. MUDr. M. Ryska, Csc. |
|
Summary:
Structured Abstract
Objective: Analysis of nodal pelvic and paraaortal findings in patients operated on for ovarian
cancer.
Design: Retrospective study.
Setting: Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University,
Prague.
Methods: Analysis of a series of 30 patients - assesment of median age, staging, grading, histologi-
cal findings, percentage of pelvic and paraaortic nodal involvement, median number of lympho-
nodes.
Results: Median age of the series was 54 years, 15 patients had an early ovarian cancer and 15
patients advanced ovarian cancer. Paraaortal lymphadenectomy revealed metastatic involvement
of lymphonodes in 8/30 cases (26,7%) and pelvic lymphadenectomy in 4/18 cases (22,7%). Involve-
ment of any lymphonodes had 9 patients (30%). In a group of patients with early ovarian cancer
no case had a nodal involvement, in a group of advanced ovarian cancer 9/15 (60%) patients were
positive. Median numbers of removed pelvic and paraaortal lymphonodes were 8,3 resp. 5,4 nodes.
Conclusion: Pelvic and paraaortal lymphadenectomy in ovarian cancer have especially a staging
importance with adequate therapeutic consequencies. Currently a sampling extent of operation is
preferred to systematic lymphadenectomy. It is recommended to concentrate operations to onco-
gynecological centers.
Key words:
ovarian cancer, paraaortal lymphadenectomy
|